false 0001892322 DE 0001892322 2023-11-13 2023-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 13, 2023

 

HEARTCORE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41272   87-0913420

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

1-2-33, Higashigotanda, Shinagawa-ku, Tokyo, Japan

(Address of principal executive offices)

 

+81-3-6409-6966

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HTCR   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On November 13, 2023, HeartCore Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2023. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in any website is not a part of this Current Report on Form 8-K.

 

The information included in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

No.

  Description
 99.1   Press release of the registrant issued November 13, 2023.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEARTCORE ENTERPRISES, INC.
   
Dated: November 13, 2023 By: /s/ Sumitaka Yamamoto
  Name: Sumitaka Yamamoto
  Title: Chief Executive Officer

 

 

 

Exhibit 99.1

 

 

HeartCore Reports Third Quarter 2023 Financial Results

 

NEW YORK and TOKYO, November 13, 2023 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the third quarter ended September 30, 2023.

 

Third Quarter 2023 and Recent Operational Highlights

 

Q3 2023 Revenue of $4.7 million, 150% higher than Q3 2022.
Enterprise software revenue doubled compared to Q3 2022.
Consulting services revenues were only approximately $612,000, as client IPOs have been moved to Q4 2023.
Year-to-Date 2023 revenue of $18.5 million, 172% higher than Q3 2022.
Year-to-Date 2023 Net Loss of $1.8 million, or $(0.07) per share.
Launched its digital experience platform, Daishiwake platform into the U.S. and Japanese markets.
Awarded top market share (15%) in Japan for its CMS platform for eight consecutive years.
Signed eleventh Go IPO contract with GATES GROUP Inc.
Hired the New York-based sales team of Sabatini Global, further augmenting the Company’s headcount in the U.S.
Hosted Nasdaq Listing Guidance seminar for Japanese companies as part of the Company’s Go IPO business development efforts.
Engaged licensing agreement with Marushin Corporation for CONTROLIO software.
Partnered with INTRIX, Inc. to license HeartCore’s Content Management System (CMS).

 

Management Commentary

 

“HeartCore’s transformation continued in the third quarter, as we made progress across all facets of our business operations,” said CEO Sumitaka Kanno Yamamoto. “In October, our Content Management System (CMS) platform was awarded as the solution with top market share in Japan for the eighth consecutive year by ITR Corporation, an independent IT consulting research firm. As the market leader in Japan, we are now focused on growing our global footprint. Our acquisition of Sigmaways and the hiring of the New York-based sales team of Sabatini Global provides talented individuals and new technologies to expand our business in the dynamic U.S. market.

 

“The second and third quarters of 2023 did not turn out exactly like we expected for our consulting service clients, as the IPO market was turbulent, and markets were faced with rising interest rates and economic uncertainty. During the first nine months of 2023, we generated $6.4 million in revenue, primarily from valuation of warrants from our GO IPO consulting services business. Nearly all of that, over $5 million, occurred in the first quarter 2023 when two of our clients launched their IPOs. We have entered into consulting agreements with 11 companies to assist them in their IPO process. With two of them across the finish line and three more companies slated to IPO soon, we anticipate this segment of the business to be a vital growth engine for our organization that will drive significant revenue growth and add value to our balance sheet in the coming quarters.”

 

Third Quarter 2023 Financial Results

 

Revenues increased 150.4% to $4.7 million compared to $1.9 million in the same period last year. The increase was primarily due to increased revenue from customized software development and services as a result of the acquisition of Sigmaways and its subsidiaries, and an increase from Go IPO consulting services as the Company obtained more IPO consulting customers in 2023.

 

 

 

 

 

Gross profit increased 151.7% to $0.8 million from $0.3 million in the same period last year. The increase was primarily from increased maintenance and support services, customized software development and services, and Go IPO consulting services.

 

Operating expenses increased to $2.6 million from $2.3 million in the same period last year. The increase was primarily due to general and administrative expenses and research and development expenses, slightly offset by decreases in selling expenses.

 

Net loss was $2.5 million or $(0.11) per diluted share, compared to a net loss of $2.0 million or $(0.11) per diluted share, in the same period last year.

 

As of September 30, 2023, the Company had cash and cash equivalents of $2.2 million compared to $7.2 million in December 31, 2022.

 

Nine Months 2023 Financial Results

 

Revenues increased 171.6% to $18.5 million compared to $6.8 million in the same period last year. The increase was primarily due to an increase in Go IPO consulting service revenues and received warrants from customers, and an increase from customized software development and services as a result of Sigmaways and its subsidiaries.

 

Gross profit increased 176.5% to $8.0 million from $2.9 million in the same period last year. The increase was primarily due to an increase in Go IPO consulting service revenues and received warrants from customers, and an increase from customized software development and services as a result of Sigmaways and its subsidiaries.

 

Operating expenses increased to $8.9 million from $8.1 million in the same period last year. The increase was primarily due to increases in general and administrative expenses, offset by a decrease in selling expense, and research and development expenses.

 

Net loss was about $1.8 million or $(0.07) per diluted share compared to a net loss of $5.3 million or $(0.29) per diluted share, in the same period last year.

 

About HeartCore Enterprises, Inc.

 

Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company’s products and services is available at and https://heartcore-enterprises.com/.

 

 

 

 

 

Forward-Looking Statements

 

All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

HeartCore Investor Relations Contact:

 

Gateway Group, Inc.

Matt Glover and John Yi

HTCR@gateway-grp.com

(949) 574-3860

 

 

 

 

 

HeartCore Enterprises, Inc.

Unaudited Consolidated Statements of Operations and Comprehensive Loss

 

   For the nine months ended
September 30,
   For the three months ended
September 30,
 
   2023   2022   2023   2022 
                 
Revenues  $18,518,431   $6,818,774   $4,688,908   $1,872,476 
Cost of revenues   10,548,245    3,935,908    3,860,241    1,543,256 
Gross profit   7,970,186    2,882,866    828,667    329,220 
                     
Operating expenses:                    
Selling expenses   1,330,747    1,706,250    274,043    771,496 
General and administrative expenses   7,305,392    5,832,276    2,172,298    1,513,028 
Research and development expenses   289,303    583,762    170,071    58,275 
Total operating expenses   8,925,442    8,122,288    2,616,412    2,342,799 
                     
Loss from operations   (955,256)   (5,239,422)   (1,787,745)   (2,013,579)
                     
Other income (expenses):                    
Changes in fair value of investments in marketable securities   (500,762)   -    (271,740)   - 
Changes in fair value of investments in warrants   (294,565)   -    (460,672)   - 
Interest income   64,633    32,256    14,363    21,707 
Interest expenses   (125,073)   (39,361)   (42,619)   (10,500)
Other income   176,641    40,645    52,640    15,195 
Other expenses   (62,701)   (58,050)   (25,947)   (2,826)
Total other income (expenses)   (741,827)   (24,510)   (733,975)   23,576 
                     
Loss before income tax provision   (1,697,083)   (5,263,932)   (2,521,720)   (1,990,003)
                     
Income tax expense (benefit)   58,859    (10,906)   19,413    (19,069)
                     
Net loss   (1,755,942)   (5,253,026)   (2,541,133)   (1,970,934)
Less: net loss attributable to non-controlling interest   (419,211)   -    (233,913)   - 
Net loss attributable to HeartCore Enterprises, Inc.  $(1,336,731)  $(5,253,026)  $(2,307,220)  $(1,970,934)
                     
Other comprehensive income (loss):                    
Foreign currency translation adjustment   (85,244)   428,118    (90,743)   128,705 
                     
Total comprehensive loss   (1,841,186)   (4,824,908)   (2,631,876)   (1,842,229)
Less: comprehensive loss attributable to non-controlling interest   (422,352)   -    (235,094)   - 
Comprehensive loss attributable to HeartCore Enterprises, Inc.  $(1,418,834)  $(4,824,908)  $(2,396,782)  $(1,842,229)
                     
Net loss per common share attributable to HeartCore Enterprises, Inc.                    
Basic  $(0.07)  $(0.29)  $(0.11)  $(0.11)
Diluted  $(0.07)  $(0.29)  $(0.11)  $(0.11)
                     
Weighted average common shares outstanding                    
Basic   20,257,020    18,014,483    20,842,690    17,835,027 
Diluted   20,257,020    18,014,483    20,842,690    17,835,027 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

 

 

HeartCore Enterprises, Inc.

Consolidated Balance Sheets

 

   September 30,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS          
           
Current assets:          
Cash and cash equivalents  $2,199,565   $7,177,326 
Accounts receivable   2,562,239    551,064 
Investments in marketable securities   757,106    - 
Prepaid expenses   683,327    538,230 
Note receivable   300,000    - 
Current portion of long-term note receivable   100,000    - 
Due from related party   42,439    48,447 
Other current assets   111,326    220,070 
Total current assets   6,756,002    8,535,137 
           
Non-current assets:          
Property and equipment, net   752,940    203,627 
Operating lease right-of-use assets   2,413,814    2,644,957 
Intangible asset, net   4,675,000    - 
Goodwill   3,276,441    - 
Long-term investments in warrants   2,456,902    - 
Long-term note receivable   200,000    - 
Deferred tax assets   222,172    263,339 
Security deposits   338,220    244,395 
Long-term loan receivable from related party   184,076    246,472 
Other non-current assets   67    661 
Total non-current assets   14,519,632    3,603,451 
           
Total assets  $21,275,634   $12,138,588 
           
 LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable and accrued expenses  $1,779,953   $497,742 
Accrued payroll and other employee costs   558,394    360,222 
Due to related party   7,859    402 
Current portion of long-term debts   525,440    697,877 
Insurance premium financing   122,279    - 
Factoring liability   217,250    - 
Operating lease liabilities, current   365,241    291,863 
Finance lease liabilities, current   17,076    19,294 
Income tax payables   103,935    2,747 
Deferred revenue   1,740,877    1,724,519 
Other current liabilities   222,089    53,027 
Total current liabilities   5,660,393    3,647,693 
           
Non-current liabilities:          
Long-term debts   1,351,830    1,123,735 
Operating lease liabilities, non-current   2,113,917    2,421,054 
Finance lease liabilities, non-current   68,535    459 
Deferred tax liabilities   1,309,000    - 
Other non-current liabilities   197,817    138,018 
Total non-current liabilities   5,041,099    3,683,266 
           
Total liabilities   10,701,492    7,330,959 
           
Shareholders’ equity:          
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively)   -    - 
Common shares ($0.0001 par value, 200,000,000 shares authorized; 20,842,690 and 17,649,886 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively)   2,083    1,764 
Additional paid-in capital   19,431,987    15,014,607 
Accumulated deficit   (11,910,310)   (10,573,579)
Accumulated other comprehensive income   282,734    364,837 
Total HeartCore Enterprises, Inc. shareholders’ equity   7,806,494    4,807,629 
Non-controlling interest   2,767,648    - 
Total shareholders’ equity   10,574,142    4,807,629 
           
Total liabilities and shareholders’ equity  $21,275,634   $12,138,588 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

 

 

HeartCore Enterprises, Inc.

Unaudited Consolidated Statements of Cash Flows

 

   For the nine months ended September 30, 
   2023   2022 
         
Cash flows from operating activities          
Net loss  $(1,755,942)  $(5,253,026)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization expenses   495,200    64,398 
Gain on disposal of property and equipment   (4,737)   - 
Amortization of debt issuance costs   2,257    3,051 
Non-cash lease expense   254,876    207,549 
Loss on termination of lease   76    - 
Deferred income taxes   (109,690)   (5,843)
Stock-based compensation   1,267,699    1,225,477 
Warrants received as noncash consideration   (4,009,335)   - 
Changes in fair value of investments in marketable securities   500,762    - 
Changes in fair value of investments in warrants   294,565    - 
Changes in assets and liabilities:          
Accounts receivable   (322,583)   168,021 
Prepaid expenses   187,269    (56,553)
Other assets   (23,982)   (142,967)
Accounts payable and accrued expenses   597,247    (96,238)
Accrued payroll and other employee costs   7,471    59,059 
Due to related party   7,562    3,098 
Operating lease liabilities   (231,499)   (213,691)
Finance lease liabilities   -    (370)
Income tax payables   101,058    (7,704)
Deferred revenue   200,256    45,938 
Other liabilities   83,809    (206,569)
Net cash flows used in operating activities   (2,457,661)   (4,206,370)
           
Cash flows from investing activities          
Purchases of property and equipment   (516,658)   (41,672)
Proceeds from disposal of property and equipment   24,935    - 
Advances on note receivable   (600,000)   - 
Repayment of loan provided to related party   34,823    33,042 
Payment for acquisition of subsidiary, net of cash acquired   (724,910)   - 
Net cash flows used in investing activities   (1,781,810)   (8,630)
           
Cash flows from financing activities          
Proceeds from initial public offering, net of issuance cost   -    13,602,554 
Proceeds from issuance of common shares prior to initial public offering   -    220,572 
Repurchase of common shares   -    (3,500,000)
Payments for finance leases   (16,537)   (29,051)
Proceeds from long-term debt   219,427    258,087 
Repayment of long-term debts   (584,779)   (699,407)
Repayment of insurance premium financing   (266,756)   (298,886)
Net proceeds from factoring arrangement   217,250    - 
Payments for debt issuance costs   (656)   (1,030)
Payment for mandatorily redeemable financial interest   -    (430,489)
Net cash flows provided by (used in) financing activities   (432,051)   9,122,350 
           
Effect of exchange rate changes   (306,239)   (200,981)
           
Net change in cash and cash equivalents   (4,977,761)   4,706,369 
           
Cash and cash equivalents - beginning of the period   7,177,326    3,136,839 
           
Cash and cash equivalents - end of the period  $2,199,565   $7,843,208 
    -      
Supplemental cash flow disclosures:          
Interest paid  $59,290   $38,387 
Income taxes paid  $91,657   $3,013 
           
Non-cash investing and financing transactions          
Payroll withheld as repayment of loan receivable from employees  $-   $12,034 
Liabilities assumed in connection with purchase of property and equipment  $9,602   $17,731 
Share repurchase liability settled by issuance of common shares  $-   $16 
Operating lease right-of-use asset obtained in exchange for operating lease liability  $317,040   $- 
Finance lease right-of-use asset obtained in exchange for finance lease liability  $93,117   $- 
Remeasurement of operating lease liability and right-of-use asset due to lease modification   12,579    - 
Deferred offering costs recognized against the proceeds from the offering  $-   $178,847 
Insurance premium financing  $389,035   $388,538 
Common shares issued for acquisition of subsidiary  $3,150,000   $- 
Investments in warrants converted to marketable securities  $1,257,868   $- 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

v3.23.3
Cover
Nov. 13, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 13, 2023
Entity File Number 001-41272
Entity Registrant Name HEARTCORE ENTERPRISES, INC.
Entity Central Index Key 0001892322
Entity Tax Identification Number 87-0913420
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1-2-33
Entity Address, Address Line Two Higashigotanda
Entity Address, Address Line Three Shinagawa-ku
Entity Address, City or Town Tokyo
Entity Address, Country JP
City Area Code +81-3
Local Phone Number 6409-6966
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol HTCR
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false

HeartCore Enterprises (NASDAQ:HTCR)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse HeartCore Enterprises
HeartCore Enterprises (NASDAQ:HTCR)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse HeartCore Enterprises